Clinical Trial Update: MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

The Phase 2 Meridian trial evaluating pegcetacoplan in adults with amyotrophic lateral sclerosis was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Drugs mentioned

• Pegcetacoplan (Pegcetacoplan)

Snippet

Sponsor: Apellis Pharmaceuticals, Inc. | Conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-04-24